Asia Pacific Non-Invasive Aesthetic Treatment Market

Market Introduction

Non-invasive or non-surgical aesthetic treatment refers to the aesthetic procedures that does not require any kind of surgical incision. Sometimes, minimally invasive surgeries are also considered as non-surgical procedures. Some of the commonly conducted non-invasive aesthetic treatment includes botulinum toxin injection, chemical peels, non-surgical laser treatment, and microdermabrasion amongst other.

Asia Pacific Non-Invasive Aesthetic Treatment Strategic Insights

Strategic insights for the Asia Pacific Non-Invasive Aesthetic Treatment provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific Non-Invasive Aesthetic Treatment Report Scope

Asia Pacific Non-Invasive Aesthetic Treatment Regional Insights

The geographic scope of the Asia Pacific Non-Invasive Aesthetic Treatment refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The Asia Pacific non-invasive aesthetic treatment market is expected to reach US$ 3,927.20 million by 2028 from US$ 1,470.31 million in 2021; it is estimated to grow at a CAGR of 15.1% from 2021 to 2028. The growth of the market is attributed to a few key driving factors such as availability of technologically advanced products and proliferation of medical tourism across developing countries. However, clinical risks and complications associated with medical aesthetic procedures are hindering the market growth.

Non-invasive aesthetic treatments have gained popularity in the past few years due to advantages such as minimal downtime, no scars, low cost, and less complications. The popularity and acceptance of these procedures is mainly attributed to their non-invasiveness. Besides, it has been proved that the accuracy rate of minimally invasive surgeries is greater than that of open surgeries. Non-surgical cosmetic procedures do not involve making surgical incisions and usually are considered minimally invasive. Several manufacturers are working on advanced non-invasive aesthetic treatment products. In October 2020, Alma launched its latest Alma Hybrid platform, designed to explore multiple possibilities of using ablative, non-ablative, and thermal treatments, along with testing their synergistic impact, on skin rejuvenation and scar revision. Therefore, the availability of user-friendly, technologically advanced non-invasive aesthetic treatment products is fuelling the growth of the Asia Pacific non-invasive aesthetic treatment market. On the other hand, continuously upgrading technology landscape creates a room for improvements in the existing products. This provides significant opportunities to dermatological and medical platform providers to bring innovations in their offerings. Moreover, the demand for customized treatment options has always served wider growth opportunities for market players. Therefore, ongoing technological developments in laser systems and prospering medical tourism sector are offering significant opportunities for the future growth of Asia Pacific aesthetic laser treatment market players.

Countries in Asia-Pacific are witnessing massive challenges due to the growing COVID-19 cases. To prevent the spread of virus, restrictive measures have been taken in countries such as India, South Korea, Singapore, Malaysia, and the Philippines. Considering the economic operations and geographic condition, the outbreak has affected medical tourism and manufacturing of medical equipment, laser systems, accessories. Asia-Pacific low-income countries are experiencing the shortage of healthcare infrastructure. Also, the ongoing COVID-19 pandemic has created a seismic shift in living and cosmetic habits in the region, and the beauty industry has borne a significant brunt of this shopper shake-up. This scenario is likely to have negative impact on the non-invasive aesthetic treatment market in Asia Pacific countries.

Key Market Segments

The Asia Pacific non-invasive aesthetic treatment market, based on procedure, is segmented into injectables, skin rejuvenation, and others. The injectables segment held the largest share of the market in 2020, and the market for the same segment is expected to grow at the fastest rate during the forecast period.

The Asia Pacific non-invasive aesthetic treatment market, by end user, is segmented into hospitals, clinics and medical spas, and others. The hospitals segment held the largest share of the market in 2020. Also, the same segment is anticipated to register the highest CAGR in the market during the forecast period.

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the Asia Pacific non-invasive aesthetic treatment market are the Australian College of Cosmetic Surgery (ACCS), International Medical Travel Journal (IMTJ), and International Society of Aesthetic Plastic Surgery (ISAPS).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of Asia Pacific non-invasive aesthetic treatment market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the Asia Pacific non-invasive aesthetic treatment market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Asia Pacific non-invasive aesthetic treatment market.

ASIA PACIFIC NON-INVASIVE AESTHETIC TREATMENT MARKET SEGMENTATION

By Procedure

• Injectables
  • Botulinum Toxin
  • Calcium Hydroxylapatite
  • Hyaluronic Acid
  • Polymer Filler
  • Collagen
• Skin Rejuvenation
  • Chemical Peel
  • Laser Skin Resurfacing
  • Photorejuvenation
• Others
  • Hair Removal
  • Nonsurgical Fat Reduction
  • Sclerotherapy
  • Cellulite Treatment

By

End User

• Hospitals
• Clinics and Medical Spas
• Others

By Country

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Company Profiles

• Galderma
• Alma Lasers
• Merz Pharma
• Bausch Health Companies Inc.
• Cutera Inc.
• AbbVie Inc.
• Candela Medical
• Johnson and Johnson Services, Inc.